Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
17-20 March, 2025
Natural Products ExpoNatural Products Expo
Not Confirmed
Not Confirmed
04-07 March, 2025
Not Confirmed
Not Confirmed
05-07 March, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
17-20 March, 2025
Natural Products ExpoNatural Products Expo
Industry Trade Show
Not Confirmed
04-07 March, 2025
Industry Trade Show
Not Confirmed
05-07 March, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/ai-drug-discovery-market-to-grow-30-cagr-to-reach-us-35-bn-by-2034-novo-lilly-bms-forge-deals
19 May 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/lipidor-updates-on-phase-iii-study-of-akp02-in-treatment-of-psoriasis--half-of-patients-now-recruited-301551868.html
16 Dec 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/lipidor-expands-clinical-program-announces-investment-in-new-drug-development-project-against-acne-vulgaris-301447211.html
29 Oct 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/lipidor-submits-new-patent-application-and-expands-collaboration-with-cannassure-using-lipidors-akvano-technology-for-medicinal-cannabis-products-301411934.html
27 Sep 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/lipidor-announces-approval-to-start-phase-iii-clinical-study-of-drug-candidate-akp02-for-treatment-of-psoriasis-301385432.html
01 Jul 2021
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/lipidor-ab-licence-agreement-grants-menarini-group-company-relife-srl-exclusive-rights-to-register-promote-distribute-and-market-two-new-psoriasis-drug-candidates-for-potential-value-of-meur-70-301324729.html
22 Apr 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/lipidor--update-on-the-companys-phase-iii-clinical-trial-of-drug-candidate-akp02-for-treatment-of-psoriasis-301274602.html
Services
API & Drug Product Development
ABOUT THIS PAGE